Basel, Switzerland (ots/PRNewswire) - The European Committee for Human Medicinal Products (CHMP) has confirmed that the presence of an impurity called ethyl methanesulfonate (EMS) in Roche's Viracept (nelfinavir mesylate) did not increase patients' risk of developing cancer. The discovery of the EMS impurity ...
Abbotsford, British Columbia (ots/PRNewswire) - ICS Copper Systems Ltd. (ICX:TSX.V) is pleased to announce that the Company has obtained important assays and widths from the sulphide twinning confirmation diamond drill program which is now completed. The latest results show that hole m-08-s-04 intersected 40.9 meters true thickness of 1.10% total copper and hole ...
Dublin, Ireland (ots) - Helsinn is pleased to announce that Helsinn Birex Pharmaceuticals, its drug facility in Dublin Ireland, has undergone a successful inspection by the US Food and Drug Administration (FDA) without any Form 483 observations. The FDA visit, which lasted 5 days, was a pre-approval inspection ...
University of Oxford Clinical Trial Service Unit and Epidemiological Studies Unit
London (ots/PRNewswire) - The University of Oxford Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU) proposed that the hypothesis-generating results of the SEAS trial of ezetimibe should be tested by reviewing the combined cancer results from the SHARP and IMPROVE-IT trials of ezetimibe, and reporting on the overall findings to the relevant ...
Prof Terje Pedersen, SEAS Study Principal Investigator & Head of Steering Committee
London (ots/PRNewswire) - The SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) study has investigated the effects of intensive cholesterol lowering with the combination of simvastatin (40 mg daily) and ezetimibe (10 mg daily) in patients with aortic stenosis. Aortic stenosis (which involves partial blockage of the aortic valve in the heart) is a relatively ...
Prof Terje Pedersen, SEAS Study Principal Investigator & Head of Steering Committee
London (ots/PRNewswire) - In the news release, "Update on the SEAS Study" issued on 21 Jul 2008 07:00 GMT, by Prof Terje Pedersen,SEAS Study Principal Investigator & Head of Steering Committee over PR Newswire, we are advised by a representative of the organisation that the following information has been ...
Prof Terje Pedersen, SEAS Study Principal Investigator & Head of Steering Committee
London (ots/PRNewswire) - Professor Terje Pedersen (Ullevål University Hospital, Oslo, Norway), lead investigator for the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) Study, will provide an update on the study on Monday the 21st July. Also present in London will be Sir Richard Peto (Professor of Medical Statistics and Epidemiology and Co-director of the Clinical Trials Service Unit, University of Oxford) Professor Rory Collins (BHF Professor of Medicine and ...
Calgary, Canada (ots/PRNewswire) - - RVX-208 is the Only Apo-Al/HDL Drug to be Highlighted Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) is pleased to announce that Resverlogix's lead drug is featured prominently in an article titled "Emerging Antidyslipidemic Drugs", which appears in the current edition of Expert Opinion of Emerging Drugs, a well respected scientific journal for the ...
Hoofddorp, The Netherlands (ots/PRNewswire) - - Group Leadership Structure Re-aligned - Four Regional Presidents to Drive Growth - CEO John Pattullo: "This will bring us even closer to customers." CEVA Logistics, one of the leading supply chain companies in the world, today announced a major restructure. Effective immediately, four Regional Presidents will be responsible for running the integrated ...
Toronto (ots/PRNewswire) - - Donation to Charity With Each Card TORONTO, July 16 /PRNewswire/ -- Imagine being able to mail your friends a personalized postcard and have it delivered to their mailbox without ever having to step into a store or post office. Then imagine the time you'll save not having to find a store that sells postcards, choose the "best" generic card and make your way to the post office ...
Vancouver, Canada (ots/PRNewswire) - Mawson Resources Limited ("Mawson") TSX - MAW; Frankfurt - MRY. Michael Hudson, President & CEO provides an updated resource calculation for the Kläppibäcken uranium project in northern Sweden following completion of a 20 hole drilling program. The new resource calculation is a 51% increase in measured plus indicated categories ...
San Jose, California (ots/PRNewswire) - Atmel(R) Corporation (Nasdaq: ATML) announced today the availability of a new family of AVR(R) 8-bit microcontrollers for LIN Automotive networking applications. The ATtiny167 is the first device and is optimized to LIN slave applications. It will be qualified to AECQ-100 grade 0 and sustain ambient temperatures of up to ...
Turnhout, Belgium (ots/PRNewswire) - Max Planck Innovation, the technology transfer agency of the Max Planck Society based in Munich, Germany and Dafra Pharma R&D, a Belgian research company belonging to Dafra Pharma International, today signed a license agreement for the development and commercialisation of a ...
London (ots/PRNewswire) - The 13 members of the Organization of Petroleum Exporting Countries (OPEC) pumped an average 32.47 million barrels per day (b/d) of crude oil in June, an increase of 230,000 b/d from the May level of 32.24 million b/d, according to the latest Platts survey of OPEC and oil industry ...
Palo Alto, California and Tokyo (ots/PRNewswire) - HP and Sony Corporation today announced an agreement to create the next generation Digital Audio Tape (http://www.datmgm.com/) format - the DAT 320 - providing improved performance and capacity over existing DAT drives. HP and Sony are jointly developing the DAT or Digital Data Storage (DDS) standard, but will ...
Washington (ots/PRNewswire) - The escalating price tag for the proposed Alaska natural gas pipeline is the biggest obstacle facing the massive project, the top US official coordinating permitting said here on Monday. Appearing at the latest Platts Energy Podium event in Washington, Federal Coordinator of ...
Antony, France (ots/PRNewswire) - - 1st Half-Year Sales Up 16% - Revision Upwards of 2008 Sales Growth Guidance: (greater than or equal to)12% ANTONY, France, July 10 /PRNewswire/ -- EUR millions 2006 2007 07/06 2008 08/07 EURM %Sales EURM %Sales % EURM %Sales % ...
Toronto, Canada (ots/PRNewswire) - Angoss Software Corporation (Angoss) (TSX-V: ANC), a leading provider of data mining and predictive analytics solutions for the financial services and information and communications technology industries, today announced that it has been positioned by Gartner, Inc. in ...
Calgary, Canada (ots/PRNewswire) - Resverlogix Corp's ("Resverlogix" or the "Company") (TSX:RVX) novel lead ApoA-I drug candidate, RVX-208 has been selected as one of the top 10 most promising cardiovascular disease (CVD) drugs available for strategic partnering by an independent committee assembled by Windhover Information, a leading provider of business ...
Rousset, France (ots/PRNewswire) - - AT91CAP9S Recognized by Electronique Magazine as Best Product in Microprocessors and Memories Category Atmel(R) Corporation (Nasdaq: ATML) announced today that its AT91CAP9S customizable microcontroller, that uses the ARM926EJ-S(TM) processor, has been awarded the prestigious Electron d'Or award by Electronique Magazine, ...
Dublin (ots/PRNewswire) - LINK Financial ("LINK"), the leading European purchaser and servicer of semi- and non-performing consumer receivables, today announces the opening of its latest operational centre. The new Dublin-based facility increases LINK's total number of workstations to over 900 across 5 European countries and builds on its existing offices in London, Madrid, Rome, Cologne and Caerphilly (Wales). ...
Maidenhead, England (ots/PRNewswire) - - New Dosing Option Provides Greater Flexibility and Convenience for Patients to Effectively Control the Debilitating Symptoms of their Condition(1) The European Commission announced today a new 50 mg Enbrel(R) (etanercept) once weekly dosage regimen as an ...
Montevideo (ots/PRNewswire) - The Republic of Uruguay, in accordance with the schedule of its offer launched on June 24, 2008 to holders of 14 series of outstanding foreign currency external bonds of Uruguay (the "Eligible Bonds") outside the United States (the "International Offer"), announced today that it expects to issue: (a) U.S.$134.96 million aggregate principal amount of its U.S. Dollar 7.625% Bonds due ...
Maidenhead, England (ots/PRNewswire) - - PREVENAR Vaccine to Help Protect Children Against the Leading Vaccine-Preventable Cause of Death in Young Children Wyeth applauds the countries of Cyprus, Hungary, the Kingdom of Bahrain, Republic of Ireland, Slovak Republic and Sweden for announcing their ...
Maidenhead, England (ots/PRNewswire) - - First-in-Class Treatment set to Provide a New and Important Targeted Treatment for Distressing and near Universal Side Effect in Patients Receiving Opioids for Pain Relief as Part of Palliative Care Wyeth Pharmaceuticals, today 3rd July, announced that it ...
Barcelona (ots/PRNewswire) - The winners of the Ferring Research Infertility and Gynaecology GrAnt (FRIGGA) are announced today at the European Society for Human Reproduction & Embryology Congress. The two winners of this new prize are the University Medical Centre Utrecht, The Netherlands and the Universitair Ziekenhuis (UZ) Brussel, Centre for Reproductive ...
Southampton, England (ots/PRNewswire) - - First of a new generation of capacitive touch sense ICs Atmel(C) Corporation (Nasdaq: ATML) announced today the AT42QT2160 -- a touch controller IC combining touch key and touch slider functions in a single device. The AT42QT2160 can control up to 16 individual ...
Turnhout, Belgium (ots/PRNewswire) - Movetis NV, a European specialist pharmaceutical company, today announced that M0002 is progressing to phase IIb following positive results of a phase IIa multiple-dosing trial for the treatment of ascites, the accumulation of fluid in the abdomen in patients with liver ...
Abbott Park, Illinois (ots/PRNewswire) - - XIENCE V, Only Drug Eluting Stent to Demonstrate Superiority Over Market-Leading Stent in Clinical Trials, Now Available in United States for Treatment of Coronary Artery Disease Abbott today announced that the U.S. Food and Drug Administration (FDA) approved the XIENCE(TM) V Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease. XIENCE ...
Geneva (ots) - MKS Finance has relaunched its company Web site. This includes a brand new design as well as daily reports on the precious metals market with live prices and charts showing price development. The site www.mks.ch has been refreshed with round-the-clock information on precious metals prices and daily analyses of important events in the financial markets. The web site also features the well-researched ...